These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17175058)

  • 1. Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer.
    Campa D; Zienolddiny S; Lind H; Ryberg D; Skaug V; Canzian F; Haugen A
    Lung Cancer; 2007 Apr; 56(1):17-23. PubMed ID: 17175058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
    Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
    Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
    Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
    Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk.
    Gemignani F; Landi S; Moreno V; Gioia-Patricola L; Chabrier A; Guino E; Navarro M; Cambray M; Capellà G; Canzian F
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1633-8. PubMed ID: 16030094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age.
    Kopecková M; Paclt I; Petrásek J; Pacltová D; Malíková M; Zagatová V
    Neuro Endocrinol Lett; 2008 Apr; 29(2):246-51. PubMed ID: 18404133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer.
    Landvik NE; Hart K; Skaug V; Stangeland LB; Haugen A; Zienolddiny S
    Carcinogenesis; 2009 Jul; 30(7):1186-92. PubMed ID: 19461122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers.
    Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland LB; Canzian F; Haugen A
    Carcinogenesis; 2008 Jun; 29(6):1164-9. PubMed ID: 18258609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the association between smoking behavior and dopamine receptor D2 gene polymorphisms among lung cancer cases].
    Qi J; Tan W; Xing D; Miao X; Lin D
    Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Oct; 23(5):370-3. PubMed ID: 12482370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of interleukin-1 beta genetic polymorphism, smoking and alcohol drinking on the risk of non-small cell lung cancer.
    Wu KS; Zhou X; Zheng F; Xu XQ; Lin YH; Yang J
    Clin Chim Acta; 2010 Oct; 411(19-20):1441-6. PubMed ID: 20529668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
    Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
    Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study.
    Suzuki T; Matsuo K; Hiraki A; Saito T; Sato S; Yatabe Y; Mitsudomi T; Hida T; Ueda R; Tajima K
    Carcinogenesis; 2007 Aug; 28(8):1718-25. PubMed ID: 17468511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study.
    Vogel U; Christensen J; Wallin H; Friis S; Nexø BA; Raaschou-Nielsen O; Overvad K; Tjønneland A
    Mutat Res; 2008 Mar; 639(1-2):89-100. PubMed ID: 18164040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.
    Heist RS; Zhai R; Liu G; Zhou W; Lin X; Su L; Asomaning K; Lynch TJ; Wain JC; Christiani DC
    J Clin Oncol; 2008 Feb; 26(6):856-62. PubMed ID: 18281657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
    Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
    Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in the vitamin D receptor gene and risk of lung cancer.
    Dogan I; Onen HI; Yurdakul AS; Konac E; Ozturk C; Varol A; Ekmekci A
    Med Sci Monit; 2009 Aug; 15(8):BR232-42. PubMed ID: 19644412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample.
    Manchia M; Congiu D; Squassina A; Lampus S; Ardau R; Chillotti C; Severino G; Del Zompo M
    Psychiatry Res; 2009 Sep; 169(2):164-6. PubMed ID: 19647327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.
    Gabriela ML; John DG; Magdalena BV; Ariadna GS; Francisco de LP; Liz SM; Lino PC; Josefina RG; Ernesto RZ; Carlos CF
    Neurosci Lett; 2009 Feb; 451(3):257-60. PubMed ID: 19146920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
    Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
    Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 gene polymorphisms and susceptibility to non-small cell lung cancer.
    Jiang B; Zhu ZZ; Liu F; Yang LJ; Zhang WY; Yuan HH; Wang JG; Hu XH; Huang G
    Genet Mol Res; 2011 Aug; 10(3):1856-65. PubMed ID: 21948749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
    Lou Y; Fang CQ; Li JH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.